It has been recently demonstrated that K-Ras GTP in association with Gal-3 contributes to the development of thyroid carcinoma, and that the Ras inhibitor FTS disrupts the interactions between K-Ras and Gal-3 and inhibits thyroid tumor growth [22]. The gene discussed is KRAS; the disease is thyroid tumor.